GDUFA III: Excipients Group Seeks Seat At Negotiating Table, But US FDA Skeptical
IPEC-Americas requests an improved communications channel with the FDA and formal inclusion in talks to reauthorize the generic drug user fee program; agency says industry negotiators generally represent product manufacturers and API suppliers that are subject to user fees.
